An exploratory assessment of the gaps for health innovation in Brazil: challenges and a proposed research agenda

Alves, Alex da Silva; Botelho, Antonio; Mendes, Luciano

doi:10.1016/j.rai.2017.03.001

Cited by 3 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Maka dengan kondisi inelastis baik pada mayoritas kabupaten/kota yang ada di regional Jawa Bali dan Papua menunjukkan adanya kemungkinan program kesehatan yang dilakukan kabupaten/kota sama setiap tahun. Rendahnya perubahan atau perkembangan program yang dilakukan oleh pemerintah menunjukkan besarnya kesenjangan antara kebutuhan masyarakat dan kecepatan pemerintah dalam melakukan inovasi di bidang kesehatan (Alves et al, 2017). masing daerah.…”

Section: Pembahasanunclassified

Komparasi Elastisitas Pembiayaan Penanggulangan Penyakit Menular Diregional Jawa Bali Dan Papua

Putri

Maryani

Rochmah

et al. 2018

hsr

View full text Add to dashboard Cite

The rapid growth and the various communicable diseases should be compensated with qualifi ed health programs. The programs’ budget should be able to meet the need of communicable disease intervention. In the era of decentralization, differences in the ability of each district in handling health problems could triger the disparity between districts. This research analyzes the difference of budget elasticity that existed in the communicable disease intervention between districts in Java Bali and Papua region. This is an analytical study which analyze the difference of communicable disease budget elasticity based on the geographic characteristics, fi scal capacity, and health status in each districts. The data is collected cross sectional in all districts that exist in Java Bali and Papua as the population. The difference of elasticity based on each indicator used in this study was analysed using independent t-test. The elasticity of communicable disease prevention fi nancing is different among districts with different public health index inJava Bali and Papua regional. Themajority of communicable disease budget in districts are inelastic, in both regions. It is different with the assumption that budget elasticity of communicable disease should be responsive. The budget elasticity of communicable disease in Indonesia is infl uenced by its health condition of each district. This condition is contrast to the ideal budget elasticity that should be elastic in accordance to the communicable disease problems. The use of economic assumption for further research should be concerns to the uncertainty of health characteristic. Abstrak Tingginya laju pertumbuhan dan bervariasinya jenis penyakit menular harus diimbangi dengan upaya penanggulangan yang responsif. Pembiayaan penanggulangan penyakit menular harus menyesuaikan dengan perkembangan penyakit menular. Di era desentralisasi, terdapat perbedaan kemampuan tiap daerah dalam pembiayaan kesehatan sehingga menyebabkan adanya disparitas penyakit antar daerah. Penelitian ini bertujuan untuk melakukan komparasi elastisitas pembiayaan yang telah dikeluarkan oleh pemerintah daerah dalam penanggulangan penyakit menular di regional Jawa Bali dan Papua. Komparasi ini dilakukan sebagai analisis lanjut Riset Pembiayaan Kesehatan tahun 2015 oleh Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Penelitian analitik ini melakukan komparasi elastisitas pembiayaan penanggulangan penyakit menular berdasarkan perbedaan karakteristik geografi , kemampuanfiskal, dan status kesehatan pada setiap kabupaten/kota yang ada di regional Jawa Bali dan Papua. Data dikumpulkan secara cross sectional pada Dinas Kesehatan kabupaten/kota yang ada di regional Jawa Bali dan Papua. Komparasi elastisitas terhadap setiap indikator yang digunakan dalam penelitian ini dianalisis menggunakan independent t-test. Elastisitas pembiayaan penanggulangan penyakit menular antar Kabupaten/Kota berbeda pada regional Jawa Bali dan Papua dengan IPKM berbeda. Kondisi pembiayaan penanggulangan penyakit menular yang seharusnya elastis, tidak terjadi pada kedua regional. Mayoritas Kabupaten/Kota cenderung inelastis dalam membiayai penanggulangan penyakit menular di masing-masing daerah. Elasitisitas pembiayaan penanggulangan penyakit menular pada Kabupaten/Kota di Indonesia dipengaruhi oleh kondisi kesehatan masing-masing daerah. Kondisi ini bertolak belakang dengan asumsipembiayaan penanggulangan penyakit menular yang harusnya responsif sesuai dengan masalah penyakit menular yang muncul. Penggunaan asumsi yang juga memperhatikan beberapa masalah kesehatan lain merupakan hal yang perlu digunakan pada penelitian selanjutnya.

show abstract

Section: Pembahasanunclassified

Komparasi Elastisitas Pembiayaan Penanggulangan Penyakit Menular Diregional Jawa Bali Dan Papua

Putri

Maryani

Rochmah

et al. 2018

hsr

View full text Add to dashboard Cite

show abstract

Business Modeling and Public Policy in High-Tech Industries: Exploratory Evidences from Two Brazilian Semiconductor Support Programs

Alves

Botelho

Duarte³

2018

Int. J. Innovation Technol. Management

View full text Add to dashboard Cite

This paper adopts an exploratory analysis based on a multiple case study to investigate the interplay of Small and Medium Enterprises (SMEs) business modeling strategies and Science, Technology and Innovation (STI) policies in a mid-income country efforts to develop a national semiconductor industry. Specifically, we analyze how 22 Brazilian SMEs supported by two comprehensive federal programs designed and implemented business models and strategies in an attempt to, on the one hand, meet the scope and timing of public funding resources and, on the other hand, develop capabilities to enter the industry’s global value chain. Drawing on a wide body of literature and on the evidence collected, we identified and categorized the firms’ business models into five groups: Pure Play IP, Pure Play Design, Fabless, Fabless Plus and Captive. We then analysed the firms’ within the specificities of each group. The paper shows that, in addition to business models and strategies oriented to meet short-term survival needs, the financial benefits for firms were low and unstable, with recurrent and unresolved frictions between policy-makers, planners and firms.

show abstract

Challenges and opportunities for pharmaceutical SMEs from South Africa in embedding into global supply chains

Takawira,

Pooe

2024

IJBES

View full text Add to dashboard Cite

The inclusion of small and medium-sized pharmaceutical companies from developing countries in global supply chains is essential for the expansion and durability of the worldwide pharmaceutical sector. South Africa, with its rapidly growing pharmaceutical industry, is leading the way in this process of integration. It provides a distinct case study of the difficulties and advantages that small and medium-sized enterprises face in the pharmaceutical sector. This study seeks to conduct a systematic analysis of the current literature about the obstacles and possibilities encountered by small and medium-sized pharmaceutical companies in South Africa as they strive to become part of global supply chains. The objective is to offer a thorough summary of the existing research in this field. This study utilised the PRISMA systematic literature review approach to evaluate 26 peer-reviewed papers and academic publications from the Scopus database that are pertinent to pharmaceutical small and medium-sized enterprises (SMEs) in South Africa. The data were extracted using Atlas-ti, which facilitated a thematic analysis to identify and categorise the primary difficulties and opportunities faced by these firms. The assessment has found four main obstacles: regulatory impediments, budgetary limitations, operational and logistical concerns, and market rivalry. On the other hand, there were also important prospects identified, such as the possibility for expanding the market, developments in technology, initiatives to promote sustainability, and the development of collaborative networks. These findings emphasise the complex and diverse ways in which small and medium-sized enterprises (SMEs) become part of global supply chains. They illustrate the obstacles and opportunities that SMEs encounter in their efforts to succeed. Pharmaceutical small and medium-sized enterprises (SMEs) in South Africa encounter a range of intricate obstacles as they strive to integrate into the global supply chain. However, they also have multiple chances to utilise growth and gain a competitive edge. Effectively managing these difficulties and possibilities is crucial for their incorporation into worldwide markets. This study enhances the scholarly discussion on the integration of global supply chains by conducting a detailed investigation of small and medium-sized pharmaceutical companies in the context of a developing country. This study provides valuable insights into the unique problems and possibilities faced by these businesses, which can be used to guide future research and develop practical strategies to enhance global integration.

show abstract

An exploratory assessment of the gaps for health innovation in Brazil: challenges and a proposed research agenda

Cited by 3 publications

References 16 publications

Komparasi Elastisitas Pembiayaan Penanggulangan Penyakit Menular Diregional Jawa Bali Dan Papua

Komparasi Elastisitas Pembiayaan Penanggulangan Penyakit Menular Diregional Jawa Bali Dan Papua

Business Modeling and Public Policy in High-Tech Industries: Exploratory Evidences from Two Brazilian Semiconductor Support Programs

Challenges and opportunities for pharmaceutical SMEs from South Africa in embedding into global supply chains

Contact Info

Product

Resources

About